| Autor: |
Vassilakopoulos, T. P., Liaskas, A., Rizzuto, G., Symeonidis, A., Palma, M., Angelopoulou, M. K., Giatra, C., Spanoudakis, E., Oikonomopoulos, P., Kondopidou, F. N., Dimou, M., Musseti, A., Xagoraris, I., Siakantaris, M., Panitsas, F., Asimakopoulos, J., Arapaki, M., Chatzidimitriou, C., Belia, M., Sachanas, S. |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p677-677, 1p |
| Abstrakt: |
TREATMENT STRATEGIES AND PROGNOSTIC FACTORS FOR THE OUTCOME OF PATIENTS WITH HODGKIN LYMPHOMA EXPERIENCING VERY LATE RELAPSES AFTER CHEMOTHERAPY ± RADIOTHERAPY B Conclusion: b The prognosis of VLRs does not appear very favorable, however a considerable proportion of patients were >=65 years old at the time of relapse when treatment options are limited and also, many patients succumb to disease-unrelated causes. B Background: b Despite the excellent long-term outcome of patients with Hodgkin Lymphoma (HL), some cases will be primary refractory or will eventually relapse, mainly within the first 2 years from diagnosis. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text